Skip to main content

Table 1 Demographics of the ADNI and UPenn datasets

From: Pathological drivers of neurodegeneration in suspected non-Alzheimer’s disease pathophysiology

 

ADNI

UPenn

A−N−

SNAP

A+N+

A−N−

SNAP

A+N+

Number (%)

6 (9.5)

14 (22.2)

35 (55.6)

11 (7.1)

47 (30.1)

76 (48.7)

Age at death (years)

84.5±3.8

83.6±8.4

82.0±6.9

68.6±5.9

68.9±9.8

74.2±11.8*

Gender (% male)

4 (66.7)

14 (100)

27 (77.1)

8 (72.7)

47 (61.8)

26 (55.3)

Time difference between MRI and date of death (years)

4.5±2.1

5.9±2.8

4.3±2.5

2.1±2.5

2.1±2.0

3.2±2.5*

Clinical diagnosis at MRI

 Control (%)

4 (66.7)

1 (7.1)

2 (5.7)

0 (0)

0 (0)

0 (0)

 MCI (%)

2 (33.3)

11 (78.6)

16 (45.7)

0 (0)

1 (2.1)

6 (7.9)

 Dementia (%)

0 (0)

2 (14.3)

17 (48.6)

11 (100)

46 (97.9)

69 (90.8)

 Others (%)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

1 (1.3)a

Latest clinical diagnosis

 Control (%)

3 (50.0)

1 (7.1)

0 (0)

0 (0)

0 (0)

0 (0)

 MCI (%)

2 (33.3)

2 (14.3)

4 (11.4)

0 (0)

1 (2.1)

4 (5.3)

 Dementia (%)

1 (16.7)

3 (78.6)

31 (88.6)

11 (100)

46 (97.9)

72 (94.7)

  1. <0.10; *p<0.05 for comparison with SNAP. aThis case had a clinical diagnosis of Parkinson’s disease but a neuropathological diagnosis of progressive supranuclear palsy. SNAP suspected non-Alzheimer’s pathophysiology, A β-amyloid, N neurodegeneration, MCI mild cognitive impairment